Investigation of SWKH, ETNB, BRNS, and VRNT Shareholders

Halper Sadeh LLC is investigating SWK Holdings Corporation, 89bio, Inc., Barinthus Biotherapeutics plc, and Verint Systems Inc. for potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders. The firm is examining the sale of SWK to Runway Growth Finance Corp., 89bio to Roche, Barinthus' merger with Clywedog Therapeutics, and Verint's sale to Thoma Bravo. Shareholders are encouraged to contact Halper Sadeh LLC for more information.

Halper Sadeh LLC, an investor rights law firm, has announced it is investigating several high-profile transactions for potential violations of federal securities laws and/or breaches of fiduciary duties to shareholders. The firm is examining the sale of SWK Holdings Corporation (NASDAQ: SWKH) to Runway Growth Finance Corp., 89bio, Inc. (NASDAQ: ETNB) to Roche, Barinthus Biotherapeutics plc (NASDAQ: BRNS) to Clywedog Therapeutics, and Verint Systems Inc. (NASDAQ: VRNT) to Thoma Bravo.

SWK Holdings Corporation, a life science-focused specialty finance company, saw its stock surge 19.8% in premarket trading after Runway Growth Finance Corp. announced its acquisition. The definitive merger agreement values SWK at approximately $220 million, with Runway Growth contributing $75.5 million in shares and $145 million in cash, according to an Investing.com report. The acquisition aims to expand Runway Growth's healthcare investments to approximately 31% of its portfolio.

89bio, Inc. shareholders are set to receive $14.50 per share in cash at closing, plus a non-tradeable contingent value right to receive up to $6.00 per share in cash upon achievement of specified milestones, according to a Halper Sadeh press release. Halper Sadeh LLC is examining whether the terms of this transaction are fair and comply with securities laws.

According to the press release, Barinthus Biotherapeutics plc shareholders will receive one share of common stock in the new combined company for each American Depositary Share or ordinary share owned. The firm is investigating the proposed merger with Clywedog Therapeutics, Inc. to ensure shareholders' interests are protected.

Verint Systems Inc. shareholders are set to receive $20.50 per share in cash upon the sale to Thoma Bravo, the release states. Halper Sadeh LLC is examining this transaction to ensure shareholders are treated fairly and that all applicable laws are followed.

Shareholders of the affected companies are encouraged to contact Halper Sadeh LLC for more information. The firm may seek increased consideration, additional disclosures, or other relief and benefits on behalf of shareholders on a contingent fee basis.